Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding …
DT Kahraman, A Karaküçük-İyidoğan… - New Journal of …, 2022 - pubs.rsc.org
Hypoxia-inducible factors (HIF) are among the targeted treatment strategies with increasing
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
[引用][C] Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis …
D Kahraman, A Karakucuk-Iyidogan… - NEW JOURNAL OF …, 2022 - avesis.cu.edu.tr
Hypoxia-inducible factors (HIF) are among the targeted treatment strategies with increasing
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis, binding …
DT Kahraman, A Karakucuk-Iyidogan, Y Saygideger… - 2022 - aperta.ulakbim.gov.tr
Hypoxia-inducible factors (HIF) are among the targeted treatment strategies with increasing
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
[PDF][PDF] Discovery of new chiral sulfonamides bearing benzoxadiazole as HIF inhibitors for non-small cell lung cancer therapy: design, microwave-assisted synthesis …
DT Kahraman, A Karaküçük-İyidoğan… - New Journal of …, 2022 - drive.google.com
Hypoxia-inducible factors (HIF) are among the targeted treatment strategies with increasing
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …
promise in lung cancer, and are known to play a role in tumour growth and other oncogenic …